Please provide your email address to receive an email when new articles are posted on . Two phase 3 trials showed levofloxacin reduces the risk for multidrug-resistant TB after household exposure.

Prevention of drug-resistant tuberculosis is a global health priority. However, trials evaluating the effectiveness of treating Mycobacterium tuberculosis infection among contacts of persons with drug ...

Worldwide, approximately 2 million children younger than 15 years of age are infected with multidrug-resistant (MDR) Mycobacterium tuberculosis, with MDR tuberculosis developing in approximately ...

Sydney researchers have found that Levofloxacin substantially reduces risk of drug-resistant tuberculosis. This discovery offers new hope against a disease that infects more than 400,000 people ...

June 21, 2011 — The US Food and Drug Administration (FDA) yesterday approved applications from 12 companies to manufacture generic versions of levofloxacin (Levaquin, Ortho-McNeil-Janssen ...

Levofloxacin, a fluoroquinolone antibiotic, was not linked to joint cartilage injuries in a nonblinded study that followed-up children for 5 years after they took the drug. As the first long-term ...

Pediatric Medical Tourism: International Patients Seeking Treatment in the United States for Malignancy and Serious Hematologic Disorders. A Review of the St Jude Experience This is a randomized ...

NEW YORK (Reuters Health) - The broad-spectrum antibiotic levofloxacin is highly effective against the bacteria that typically cause ear infections in children, according to researchers. In the ...

DEAR DR ROACH: I’m writing in to warn readers of a possible side effect of an antibiotic known as levofloxacin. I was recently treated with this medication for a sinus infection that would not clear ...

A clinical trial published in the New England Journal of Medicine showed that the oral antibiotic levofloxacin taken once-daily for six months substantially reduced the risk of developing ...